FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Sheffield Ian 2. Date of Event Requiring Statement (Month/Day/Year) 12/13/2013 3. Issuer Name and Ticker or Trading Symbol BOVIE MEDICAL CORP [BVX] (Last) (First) (Middle) C.O GREAT POINT PARTNERS, LLC, 165 MASON STREET, 3RD FLOOR 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) GREENWICH, CT 06870 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A 6% Convertible Preferred Stock (1)	  (1)	  (1)	Common Stock (1)	3,500,000 (1)	$ 2 (1)	I (1)	See Footnote (2) (2)
Common Stock Warrants (right to buy) (3)	  (3)	  (3)	Common Stock	5,250,000 (3)	$ 2.387 (3)	I (3)	See Footnote (2) (3)

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Sheffield Ian C.O GREAT POINT PARTNERS, LLC 165 MASON STREET, 3RD FLOOR GREENWICH, CT 06870	  X	  X	Â	Â
GREAT POINT PARTNERS LLC 165 MASON STREET 3RD FLOOR GREENWICH, CT 06870	Â	  X	Â	Â

Signatures

/s/ Jeffrey Jay, Senior Manaing Member, Great Point Partners, LLC		12/23/2013
**Signature of Reporting Person		Date
/s/ Ian Sheffield		12/23/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The securities will be convertible immediately into common stock (initially on a share for share basis) at any time without expiration as determined by dividing the Stated Value of the Series A 6% Convertible Preferred Stock by the then applicable conversion price.
(2)	The amounts shown represent the beneficial ownership or the issuer's securities by funds and certain managed accounts managed by Great Point Partners. LLC (the "GPP investors"), which may be deemed attributable to Mr. Sheffield because Mr. Sheffield is a Senior Associate of Great Point Partners, LLC. Mr. Sheffield serves as a director or the issuer as a designee of Great Point Partners, LLC acting on behalf of the GPP Investors, and accordingly Great Point Partners, LLC and the GPP Investors may be deemed to be a director by deputization. Great Point Partners, LLC and Mr. Sheffield each disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein. The amounts shown consist of securities collectively owned by each or Biomedical Value Fund, LP, Biomedical Institutional Value Fund, LP, Biomedical Offshore Value Fund, Ltd., WS Investments II, Class D Series of GEF-PS, LP, and David J. Morrison.
(3)	These securities may be exercisable on June 13, 2014 into shares or common stock and expire on June 13, 2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.